In This Article:
As the U.S. stock market shows signs of stabilizing with the S&P 500 and Nasdaq attempting to break their recent losing streaks, investors are keenly observing companies that demonstrate resilience and potential for growth amid economic uncertainties. In this environment, stocks with high insider ownership often attract attention, as they suggest a strong alignment between company leadership and shareholder interests, potentially indicating confidence in future performance.
Top 10 Growth Companies With High Insider Ownership In The United States
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.7% |
Duolingo (NasdaqGS:DUOL) | 14.4% | 37.1% |
Hims & Hers Health (NYSE:HIMS) | 13.2% | 21.8% |
Corcept Therapeutics (NasdaqCM:CORT) | 11.7% | 36.7% |
Coastal Financial (NasdaqGS:CCB) | 14.5% | 46.3% |
Astera Labs (NasdaqGS:ALAB) | 15.9% | 61.3% |
BBB Foods (NYSE:TBBB) | 16.2% | 41.1% |
Clene (NasdaqCM:CLNN) | 20.7% | 59.1% |
Upstart Holdings (NasdaqGS:UPST) | 12.7% | 100.1% |
Credit Acceptance (NasdaqGS:CACC) | 14.4% | 33.6% |
Here's a peek at a few of the choices from the screener.
H World Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: H World Group Limited operates leased and owned, manachised, and franchised hotels in the People’s Republic of China with a market cap of approximately $11.92 billion.
Operations: The company's revenue segments include leased and owned hotels, manachised hotels, and franchised hotels in the People’s Republic of China.
Insider Ownership: 31.4%
Earnings Growth Forecast: 21.1% p.a.
H World Group shows potential as a growth company with high insider ownership, despite recent challenges. The company's net income declined to CNY 49 million in Q4 2024 from CNY 743 million a year ago, yet it continues expanding its hotel network significantly. Revenue for the full year increased to CNY 23.89 billion, supported by strong manachised and franchised operations. Earnings are expected to grow significantly at an annual rate of 21.1%, outpacing the US market average.
-
Dive into the specifics of H World Group here with our thorough growth forecast report.
-
Our valuation report unveils the possibility H World Group's shares may be trading at a premium.
Krystal Biotech
Simply Wall St Growth Rating: ★★★★★☆
Overview: Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing genetic medicines for diseases with high unmet medical needs in the United States, with a market cap of approximately $5.45 billion.